Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$4.94 USD
+0.11 (2.28%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $5.45 +0.51 (10.32%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AQST 4.94 +0.11(2.28%)
Will AQST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AQST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AQST
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
Other News for AQST
AQST falls 0.82% on September 17, leaving the technical picture intact
AQST falls 5.25% on September 16, leaving the technical picture intact
Technical picture remains unchanged for AQST after it rises 1.78% on September 15
AQST forms Calm After Storm on September 12
Aquestive, Veeva, Oklo, BioMarin, TKO: Trending by Analysts